Figure 3From: RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximabIMRT treatment plan applying an integrated boost concept; dose distribution pterygoid muscles (a) and cavernous sinus/left orbit (b); 100% corresponding to 66 Gy; CTV1 receives a median of 66 Gy, CTV2 was prescribed 54 Gy.Back to article page